Contribution of endogenous G-protein-coupled receptor kinases to Ser129 phosphorylation of alpha-synuclein in HEK293 cells

Biochem Biophys Res Commun. 2009 Jul 3;384(3):378-82. doi: 10.1016/j.bbrc.2009.04.130. Epub 2009 May 3.

Abstract

The majority of alpha-synuclein (alphaS) deposited in Lewy bodies, the pathological hallmark of Parkinson's disease (PD), is phosphorylated at serine 129 (Ser129). Ser129 phosphorylation of alphaS has been demonstrated to enhance the alphaS toxicity to dopaminergic neurons in a Drosophila model of PD. Phosphorylation of alphaS at Ser129 seems to play a crucial role in the pathogenesis of PD. Here, we assessed the contribution of ubiquitously expressing members of the G-protein-coupled receptor kinase family (GRK2, GRK3, GRK5, and GRK6) to Ser129 phosphorylation of alphaS in HEK293 cells. To selectively reduce the endogenous expression of each member of the GRK family in cells, we used small interfering RNAs. Knockdown of GRK3 or GRK6 significantly decreased Ser129 phosphorylation of alphaS; however, knockdown of GRK2 or GRK5 did not decrease alphaS phosphorylation. The results indicate that endogenous GRK3 and GRK6, but not GRK2 or GRK5, contribute to Ser129 phosphorylation of alphaS in HEK293 cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • G-Protein-Coupled Receptor Kinases / metabolism*
  • Humans
  • Lewy Bodies / metabolism
  • Parkinson Disease / metabolism*
  • Phosphorylation
  • Serine / metabolism*
  • alpha-Synuclein / metabolism*

Substances

  • alpha-Synuclein
  • Serine
  • G-Protein-Coupled Receptor Kinases